Specifically, this study included 5018 RA cases and 14974 controls from the UK, Sweden, Canada, and the United States, as well as a South Korean collection of 616 RA cases and 675 controls, all of them being positive for ACPA. The gene discussed is PRTN3; the disease is rheumatoid arthritis.